Is FDA slowing down the progress in clinical cell therapy?
Note: There is a print link embedded within this post, please visit this post to print it. This question is currently highly discussed in professional communities. Professionals think that too strict...
View ArticleClik here to view.
Distinction between cell therapy and regenerative medicine
The definition of regenerative medicine that we are using right now was coined by Chris Mason a few years ago and states Regenerative medicine – Replaces or regenerates human cells, tissues or organs,...
View ArticleThe concept of “peak serum” in cell therapy products manufacturing
I’m sure everybody heard of the “peak oil” concept. Analogous to “peak oil”, David Brindley and co-authors have proposed so-called “peak serum” concept in cell therapy manufacturing. You can read...
View ArticleRegenerative medicine and cell therapy industry in 2011
At the end of the year I’d like to overview the most notable events in cell therapy and regenerative medicine industry. What made the headlines in mass media? What events were highly discussed in...
View ArticleCrackdown on “stem cell treatment” fraud in US
The recent FBI indictments in “stem cell therapy” fraud caused a big buzz in professional community. I’d like to link to some opinions: American scientist arrested in stem-cell clinic sting (Nature...
View ArticleClik here to view.
Public cell therapy and stem cell companies in 2011
Today, I’d like to look at how well public cell therapy and stem cell companies were doing on the market in 2011. By analyzing data, available for public, we can learn about trust and investor...
View ArticleThe definition of stem cell therapy
This is re-blog from Hematopoiesis.info Note: There is a print link embedded within this post, please visit this post to print it. Today everyone is talking about stem cell therapy everywhere. It’s...
View ArticleClik here to view.
Stem cell therapeutic products on the market
Updated on Mar. 6, 2012 Last year I wrote about some regenerative medicine and cell therapy products on the market. You can find updated list here. But what is the value of stem cell products among...
View ArticleClik here to view.
Regenerative medicine funding trends in US
Funding is one of the main hurdles for regenerative medicine/ cell therapy translation into the clinic. It was suggested in few conferences that government agencies should recognize the importance of...
View ArticleRegenerative medicine and cell therapy industry in 2012
As usual, at the end of the year, I overview the most interesting and important events in cell therapy and Regen industry. The list of top 10 events reflects solely my opinion. 1. Debate on regulation...
View ArticleClinical cell processing news – part 1, 2013
Clinical Cell Processing News series highlights and reviews new products and techniques for clinical-grade cell processing and manufacturing. Cell processing devices, cultureware, bioreactors,...
View ArticleClik here to view.
Autologous versus allogeneic business model
There are two major business models in cell therapy and regenerative medicine industry – autologous and allogeneic. Each model has pros and cons. I’d briefly summarize features of each model as the...
View ArticleImportance of cell supernatant control
It is important to know the mechanism of therapeutic action of transplanted cells. Multiple mechanisms could be involved in cell-mediated therapeutic effects, such as: differentiation, endogenous...
View ArticleBig Pharma acquires stem cell, RegenMed and cell therapy assets
While ago, I’ve written about relationships between Pharma/ Biotech and cell therapy industry. Few years back, Pharma still was curious and “sniffing air” around, but what about now? This year, I’ve...
View Article10 new companies to watch
I’ve decided to do an experiment and overview some new companies that I like. If you like the idea, I can do it 1-2 times per year. You can suggest new cool companies to me. In order to pick companies...
View ArticleRegenMed, stem cell and cell therapy industry in 2013
At the end of the year, I overview the most interesting and important events in stem cell/ RegenMed/ cell therapy industry. This year I’d like to focus on trends, rather than separate events. Here is...
View ArticleCell therapy industry – expectations for 2014
Today, I’d like to highlight few trends and events, which will or could happen this year in cell therapy industry field. I don’t like to predict, so, I’d rather list some expectations. The field is...
View ArticleNot Lost in Translation: Standards in cell therapy
This is a sixth post of the series “Not Lost in Translation“. If you’re trying to develop a cellular product and just entering the field of cell therapy, you should be aware of existent standards. Why...
View Article10 new companies to watch – part 2
5 months ago I’ve picked and brought to your attention a list of new interesting companies. In the last few months, I’ve learned more companies, and today, I’m sharing the new list of 10 with you. As...
View ArticleClik here to view.
The role of translational centers in regenerative medicine industry
Cell-based products are very complex and represent unique class of therapeutic biologics. Unlike Biotech and Pharma, the vast majority of cell-/ regenerative medicine (RM) products are created in...
View Article
